Latest News
Conference Coverage
Which antidiabetic for elderly patients? It depends on their CV risk
Balancing heart failure with cardiovascular events
Latest News
Survey puts a price on health improvement
Forty percent of Americans say that they need a financial incentive to exercise.
Conference Coverage
In MS, the challenges for women are unique
SEATTLE – In treating women with MS, sexuality, pregnancy, and menopause all require specific attention.
Conference Coverage
CGMs on the rise: New goals set time in range
The targets “should be considered an integral component of CGM data analysis and day-to-day treatment decision making.”
Conference Coverage
Triplet offers longest PFS yet seen in relapsed/refractory myeloma
CHICAGO – Patients who received isatuximab plus pomalidomide and dexamethasone had a median progression-free survival of 11.53 months.
Conference Coverage
Drastic weight loss prevents progression to type 2 diabetes, PREVIEW data suggest
SAN FRANCISCO – In patients with prediabetes, weight loss of 8% or more over 2 months reduced conversion to diabetes over 3 years.
Conference Coverage
Four-drug combo bests triplet in newly diagnosed myeloma
CHICAGO – Results with daratumumab plus bortezomib, thalidomide, and dexamethasone are the “best ever reported in the setting of stem cell...
Conference Coverage
Pregnancy deemed safe in BRCA-mutated breast cancer survivors
Pregnancy did not affect disease-free or overall survival, and complications were similar to the general population.
Conference Coverage
Mutant huntingtin and neurofilament light are potential biomarkers in Huntington’s disease
PHILADELPHIA – The biomarkers successfully distinguish between healthy controls, patients with premanifest disease,...
Conference Coverage
Pivotal trial shows HFrEF benefits from baroreceptor stimulation
SAN FRANCISCO – Baroreflex activation therapy showed safety and 6-month efficacy in its FDA-approved pivotal trial.